Funding momentum ANRF is a mid-sized nonprofit focused on early-stage autoimmune research funding with recent leadership appointments and a new evergreen venture fund, signaling potential for expanded programmatic partnerships and sponsored research initiatives.

Leadership appointments Recent hire of Schalon Newton as Principal of Immune Boost Capital indicates strategic emphasis on philanthropy-backed ventures and scalable funding models, presenting opportunities for co-investment, grants, and collaborative programs.

Event presence Active participation in industry events such as ACR Convergence 2025 suggests opportunities to engage through sponsorships, speaking slots, or corporate partnerships aligned with arthritis and autoimmune research communities.

Partnership history Past collaborations with wellness brands and consumer product companies (Chil Wellness, Kendra Scott) demonstrate openness to non-traditional partnerships that combine fundraising, awareness, and product-driven campaigns.

Financial scale Revenue in the 10–25 million range indicates capacity for larger grants, program expansion, or technology platforms to support grant management, applicant tracking, and impact measurement services for grantees.